A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Clinical trial NCT07662135 · RECRUITING
Trial details
- NCT number
- NCT07662135
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-06
- Primary completion
- 2028-07-13
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.